These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 18945306)

  • 41. Mycosis fungoides palmaris et plantaris--an unusual variant of cutaneous T-cell lymphoma.
    Topf S; Lüftl M; Neisius U; Brabletz T; Simon M; Schuler G; Schultz ES
    Eur J Dermatol; 2006; 16(1):84-6. PubMed ID: 16436350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon-alpha is effective for CD4(+), CCR4(-) mycosis fungoides.
    Fujimura T; Okuyama R; Watabe A; Hashimoto A; Tagami H; Aiba S
    Int J Dermatol; 2007 Apr; 46(4):435-8. PubMed ID: 17442093
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Papular mycosis fungoides: two new cases of a recently described clinicopathological variant of early mycosis fungoides.
    Martorell-Calatayud A; Botella-Estrada R; Sanmartín-Jimenez O; Requena C; Guillén-Barona C; Sangüeza OP
    J Cutan Pathol; 2010 Mar; 37(3):330-5. PubMed ID: 19737334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of Low-Dose, Low-Frequency Oral Psoralen-UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides: A Randomized Clinical Trial.
    Vieyra-Garcia P; Fink-Puches R; Porkert S; Lang R; Pöchlauer S; Ratzinger G; Tanew A; Selhofer S; Paul-Gunther S; Hofer A; Gruber-Wackernagel A; Legat F; Patra V; Quehenberger F; Cerroni L; Clark R; Wolf P
    JAMA Dermatol; 2019 May; 155(5):538-547. PubMed ID: 30892603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.
    Liu X; Wang B; Ma X; Guo Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):418-24. PubMed ID: 19395464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mycosis fungoides terminating in acute myelocytic leukemia].
    Takeoka Y; Yamane T; Koh KR; Ohta K; Nakamae H; Aoyama Y; Hirose A; Fujino Y; Inoue T; Hino M; Tatsumi N
    Rinsho Ketsueki; 2000 Sep; 41(9):755-60. PubMed ID: 11070939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group.
    Thomsen K; Hammar H; Molin L; Volden G
    Acta Derm Venereol; 1989; 69(6):536-8. PubMed ID: 2575334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
    Molin L; Thomsen K; Volden G; Groth O
    Acta Derm Venereol; 1981; 61(1):52-4. PubMed ID: 6164215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right-left comparative study.
    El-Mofty M; El-Darouty M; Salonas M; Bosseila M; Sobeih S; Leheta T; Nada H; Tawdy A; Amin I; El-Enany G
    Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):281-6. PubMed ID: 16313238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mycosis fungoides in childhood and adolescence with clonal T-cell receptor gamma gene rearrangement. Two cases].
    Krokowski M; Winzer M; Lange K; Thorns C; Gafumbegete E; Feller AC; Merz H
    Hautarzt; 2003 Jun; 54(6):536-40. PubMed ID: 12759739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ichthyosiform mycosis fungoides.
    Badawy E; D'Incan M; El Majjaoui S; Franck F; Fabricio L; Dereure O; Souteyrand P; Guillot B
    Eur J Dermatol; 2002; 12(6):594-6. PubMed ID: 12459538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality.
    Massone C; Crisman G; Kerl H; Cerroni L
    Br J Dermatol; 2008 Sep; 159(4):881-6. PubMed ID: 18644018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transformed mycosis fungoides: clinicopathological features and outcome.
    Barberio E; Thomas L; Skowron F; Balme B; Dalle S
    Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Juvenile mycosis fungoides with large-cell transformation: Successful treatment with psoralen with ultraviolet A light, interferon-alfa, and localized radiation.
    Chan WH; Lewis DJ; Hinojosa T; Curry JL; Duvic M
    Pediatr Dermatol; 2018 Jan; 35(1):e13-e16. PubMed ID: 29159918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Folliculotropic mycosis fungoides.
    Hunzeker CM; Fangman W; Latkowski JA
    Dermatol Online J; 2007 Jan; 13(1):5. PubMed ID: 17511938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phototherapy for mycosis fungoides.
    Dogra S; Mahajan R
    Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis.
    Phan K; Ramachandran V; Fassihi H; Sebaratnam DF
    JAMA Dermatol; 2019 Mar; 155(3):335-341. PubMed ID: 30698622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD8+ poikilodermatous mycosis fungoides with a nonaggressive clinical behaviour and a good response to psoralen plus ultraviolet A treatment.
    Ada S; Güleç AT
    Br J Dermatol; 2007 Nov; 157(5):1064-6. PubMed ID: 17854364
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of mycosis fungoides with oral bexarotene combined with PUVA.
    Stern DK; Lebwohl M
    J Drugs Dermatol; 2002 Sep; 1(2):134-6. PubMed ID: 12847736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.